3. Lombard I, Vincent-Salomon A, Validire P, et al. Human papillomavirus genotype as a major determinant of the course of cervical Cancer. J Clin Oncol, 1998, 16(8): 2613-2619.
10. Byrne H M. Dissecting cancer through mathematics: from the cell to the animal model. Nat Rev Cancer, 2010, 10(3): 221-230.
[7]
2. McCloskey R, Menges C, Friedman A, et al. Human papillomavirus type 16 E6/E7 upregulation of nucleophosmin is important for proliferation and inhibition of differentiation. J Virol, 2010, 84(10): 5131-5139.
[8]
7. Cornet S, Menez-Jamet J, Lemonnier F, et al. CpG oligodeoxynucleotides activate dendritic cells in vivo and induce a functional and protective vaccine immunity against a TERT derived modified cryptic MHC class I-restricted epitope. Vaccine, 2006, 24(11): 1880-1888.
